Print

Tekmira Pharmaceuticals Corporation Provides Corporate Update and Announces Second Quarter 2012 Results  
8/15/2012 9:32:10 AM

VANCOUVER, B.C., Aug. 14, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today its financial and operating results for the second quarter ended June 30, 2012 and provided a corporate update.
//-->